|
RBM12B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.618400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.201610E-01 |
| Normal-vs-Stage2 |
8.045000E-01 |
| Normal-vs-Stage3 |
8.727200E-01 |
| Normal-vs-Stage4 |
8.516200E-01 |
| Stage1-vs-Stage2 |
2.199400E-01 |
| Stage1-vs-Stage3 |
3.553400E-01 |
| Stage1-vs-Stage4 |
3.410000E-01 |
| Stage2-vs-Stage3 |
7.331400E-01 |
| Stage2-vs-Stage4 |
9.828000E-01 |
| Stage3-vs-Stage4 |
7.648200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.936600E-01 |
| Normal-vs-AfricanAmerican |
3.151200E-01 |
| Normal-vs-Asian |
7.932200E-01 |
| Caucasian-vs-AfricanAmerican |
5.151600E-01 |
| Caucasian-vs-Asian |
9.977600E-01 |
| AfricanAmerican-vs-Asian |
8.097200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.970770E-01 |
| Normal-vs-Female |
2.484600E-01 |
| Male-vs-Female |
8.422300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.300000E-01 |
| Normal-vs-Extreme_Weight |
2.510300E-02 |
| Normal-vs-Obese |
6.562000E-01 |
| Normal-vs-Extreme_Obese |
6.557600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.707200E-01 |
| Normal_Weight-vs-Obese |
2.025600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.324200E-01 |
| Extreme_Weight-vs-Obese |
1.233770E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.503200E-01 |
| Obese-vs-Extreme_Obese |
5.858600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.725160E-01 |
| Normal-vs-Age(41-60Yrs) |
6.801600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.328030E-01 |
| Normal-vs-Age(81-100Yrs) |
5.644900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.117400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.505800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.856800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.536300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.176600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.362100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.507000E-01 |
| Normal-VS-Type2 PRCC |
3.882000E-02 |
| Normal-VS-KIRP CIMP |
1.012620E-01 |
| Normal-VS-Unclassified PRCC |
4.027600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.740400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.407630E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.317990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.995800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.644220E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.098200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.303800E-02 |
| Normal-vs-N1 |
9.753800E-02 |
| Normal-vs-N2 |
7.552200E-01 |
| N0-vs-N1 |
1.069680E-02 |
| N0-vs-N2 |
6.213000E-01 |
| N1-vs-N2 |
3.973600E-01 |
|
|
